Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,697 | 52,380 | 11,419 | 4,910 | 20,340 |
| Receivables | 11,482 | 1,538 | 176 | 133 | 526 |
| TOTAL | $55,561 | $69,026 | $22,677 | $5,698 | $21,380 |
| Non-Current Assets | |||||
| PPE Net | 14,191 | 14,033 | 14,593 | 1,918 | 17,073 |
| Investments And Advances | 0 | 341 | 488 | 0 | 577 |
| Intangibles | 2,576 | 2,680 | 2,785 | 1,033 | 4,375 |
| Other Non-Current Assets | 6,857 | 263 | 262 | 725 | 0 |
| TOTAL | $23,625 | $17,317 | $18,127 | $3,676 | $22,024 |
| Total Assets | $79,186 | $86,343 | $40,804 | $9,375 | $43,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 166 | 164 | 162 | N/A | 578 |
| Accounts payable and accrued liabilities | 4,363 | 4,317 | 4,825 | 6,586 | 1,023 |
| Accrued Expenses | 8,795 | 10,485 | 5,341 | 2,519 | 3,039 |
| Other current liabilities | N/A | N/A | N/A | 57 | N/A |
| TOTAL | $18,424 | $20,156 | $11,479 | $10,136 | $8,762 |
| Non-Current Liabilities | |||||
| Long Term Debt | 787 | 848 | 908 | N/A | 4,703 |
| Deferred Revenues | 5,101 | 5,190 | 1,151 | 974 | 4,123 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 150 | 0 |
| TOTAL | $36,924 | $36,754 | $1,162 | $370 | $48,589 |
| Total Liabilities | $55,348 | $56,910 | $12,641 | $10,506 | $57,351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053 | 1,048 | 996 | 996 | 412 |
| Common Shares | 16 | 16 | 15 | 8 | 74 |
| Retained earnings | -113,696 | -106,040 | -95,779 | -73,649 | -272,631 |
| Other shareholders' equity | 2,569 | 2,355 | 2,508 | 2,619 | -228 |
| TOTAL | $23,838 | $29,433 | $28,163 | $-1,132 | $-13,947 |
| Total Liabilities And Equity | $79,186 | $86,343 | $40,804 | $9,375 | $43,405 |